Professor Helen Rees OBE GCOB[1] D.Sc. Medicine (honoris causa) LLD (honoris causa)[2] is a medical doctor, and the founder and executive director of Wits RHI, the largest research Institute at the University of the Witwatersrand in Johannesburg, South Africa. She is a Personal Professor in the University of Witwatersrand's Department of Obstetrics and Gynaecology, co-director and co-founder of the Wits African Leadership in Vaccinology Expertise (ALIVE[3]), Honorary Professor in the Department of Clinical Research at the London School of Hygiene and Tropical Medicine and an Honorary Fellow at Cambridge University's Murray Edwards College, UK.

Early life and education

Rees obtained her Medical Degree and Masters in Social and Political Sciences from New Hall College (now Murray Edwards College) at Cambridge University, and is now a Fellow of the college.[4] For her master's degree, Rees combined social science with medical science by describing the adverse impact that the poorly managed elective induction of labour was having on both obstetric outcomes and on the experiences of women in labour.  

Rees is an alumnus of Harvard Business School having completed the HBS Senior Executive Programme for Southern Africa.

Career

Rees is internationally recognised as an award-winning global health practitioner who has dedicated her professional career to improving public health in Africa, with a focus on HIV, vaccine preventable diseases, women's health and medicines regulation.[5] In 2018, she served as the chief investigator of FACTS 001, an African follow-up study to the smaller trial from 2010, which showed that South African women who used a vaginal gel containing tenofovir before and after sex were better protected from HIV than women who did not.[6]

Rees has also chaired over 100 national and international scientific and policy committees, has over 250 [7] scientific academic publications,[8] has delivered over 400 invited plenary and keynote addresses, and contributed to the organisation of more than 100 conferences.

Committees and advisory work

Rees has served on and chaired many national and global scientific committees and boards and is widely respected for her ability to synthesize recommendations from multifaceted inputs and to link research to policy and has successfully chaired many national, regional and global committees in deliberations that have changed key strategies and policies in the African region. Rees has led national consultations at the invitation of the Ministries of Health in South Sudan, Ethiopia, Nigeria and the Democratic Republic of Congo. She is a keen advocate for increasing research capacity in LMICs.

Rees has served on expert structures and committees for WHO, UNAIDS, UNICEF, the Global Alliance for Vaccines and Immunisation and the Bill & Melinda Gates Foundation. She was the Chair of the WHO's Strategic Advisory Group of Experts on Immunization[9] and she now chairs the WHO's African Regional Technical Advisory Group on Immunization. 

Rees is recognised as a leader in global health policy and security. She has served on and chaired a number of WHO International Health Regulation (IHR) Emergency Committees. She is the Chair of WHO's IHR Emergency Committee on Polio. She co-Chairs the SAGE working group on Ebola Vaccines[10] and is a member of WHO's Scientific and Technical Advisory Group on Infectious Hazards. She is a steering committee member of the Coalition for Clinical Research for Pandemics that focuses on research priorities in low- and middle-income countries. From 2015 to 2016, she was a member of the Review Committee on the Role of the International Health Regulations (2005) in the Ebola Outbreak and Response tasked with making recommendations to WHO about steps required to improve the global response to public health emergencies. She was the Chair of the WHO SAGE Committee on the Use of Vaccines in Humanitarian Emergencies.

In the field of vaccines and epidemics Rees chairs the Gavi Vaccine Investment Strategy that is developing a priority list for procurement of vaccines between 2025 and 2030 for the world's poorest 71 countries.

Other activities

Government organizations

Non-profit organizations

  • MedAccess, Chair of the Board (since 2022)[14]
  • Coalition for Equitable ResearCh in Low-resource sEttings (CERCLE), Member of the Steering Committee[15]

Recognition

Honours

Rees has won many international and national awards for her contribution to global health and to science, specifically in 2001 receiving the Order of the British Empire[16] by Queen Elizabeth II. In 2016 she was awarded the South African National Order of the Baobab by the President of South Africa for exceptional and distinguished contributions in medicine.[17] In 2022, Rees received the platinum South African National Batho Pele Award for excellence in contribution to the South African COVID-19 response [18] and was made an Officer of the French National Order of Merit in the same year by President Emmanuel Macron for her contribution to global health and to the COVID-19 response. In 2022 the Harvard Public Health named Rees a ‘standout voice’ in African public health.[19]

Awards

In 2015, Rees was awarded the National Science and Technology Foundations’ Lifetime Achievement Award as well as the Harry Oppenheimer Fellowship[20] given to a leading scholar who has a sustained a record of outstanding research and intellectual achievement at the highest level. In 2006 she was elected as a member of the Academy of Science of South Africa (ASSAf) member, and in 2010 was awarded the SA Academy of Science's Gold Award for outstanding achievement in scientific thinking to the benefit of society. She was awarded Wits University's Vice-Chancellor's Research Award (2012), Wits’ highest research recognition, and Wits Faculty of Health Sciences recognition for dedication and achievement in research (2013). She was the London School of Hygiene and Tropical Medicine's 2011 International Heath Clark lecturer awarded to an outstanding global health practitioner. The South African National Research Forum rates her as an outstanding international scientist. She was the first person to receive the SA Department of Science and Technology's award for the ‘Distinguished Scientist recognised for outstanding contribution to improving the quality of life of women’ (2006).

Honorary degrees

Rees holds a Doctor of Science (Medicine) honoris causa from the University of London and a Doctor of Laws honoris causa from Rhodes University, South Africa.

References

  1. ↑ "Prof Helen Rees: The Order of the Baobab in Silver". www.thepresidency.gov.za. 13 September 2023.
  2. ↑ "Rhodes University honours global health researcher Professor Helen Rees". www.ru.ac.za. 13 September 2023. Retrieved 13 September 2023.
  3. ↑ "Wits ALIVE Consortium Members". www.witsalive.co.za. 13 September 2023.
  4. ↑ "Professor Helen Rees, Honorary Fellow, Murray Edwards College, Cambridge University, UK". www.murrayedwards.cam.ac.uk. 13 September 2023. Retrieved 13 September 2023.
  5. ↑ Huisman, Bienne (21 November 2022). "Face to Face: Prof Helen Rees on SAHPRA, women's rights, and her appetite for justice". Spotlight. Retrieved 13 September 2023.
  6. ↑ Donald G. McNeil Jr. (24 February 2015), Study That Paid Patients to Take H.I.V. Drugs Fails New York Times.
  7. ↑ "Research Gate: Helen Rees". ResearchGate. 13 September 2023. Retrieved 13 September 2023.
  8. ↑ "Google Scholar Helen Rees Citations". Google Scholar Helen Rees. 13 September 2023. Retrieved 13 September 2023.
  9. ↑ "Strategic Advisory Group of Experts on Immunization (SAGE)". World Health Organisation Strategic Advisory Group of Experts on Immunization (SAGE). 13 September 2023. Retrieved 13 September 2023.
  10. ↑ Andrew Ward (9 January 2015), Two Ebola vaccines given go-ahead for trials in west Africa Financial Times.
  11. ↑ "SAHPRA Board". South African Health Products Regulatory Authority. 13 September 2023. Retrieved 13 September 2023.
  12. ↑ Board South African Health Products Regulatory Authority (SAHPRA).
  13. ↑ David Pilling and Joseph Cotterill (9 February 2021), South Africa forced to overhaul vaccine plan over variant fears Financial Times.
  14. ↑ "MedAccess Board". MedAccess. 13 September 2023. Retrieved 13 September 2023.
  15. ↑ Steering Committee Coalition for Equitable ResearCh in Low-resource sEttings (CERCLE).
  16. ↑ "Professor Helen Rees challenges the HIV field". London School of Hygiene & Tropical Medicine. 3 June 2014. Retrieved 19 February 2017.
  17. ↑ "Prof Helen Rees". The Presidency, Republic of South Africa. Retrieved 18 April 2020.
  18. ↑ Child, Katherine (9 April 2020). "Helen Rees: The prof leading SA's Covid-19 drug trial". Financial Mail. Retrieved 13 September 2023.
  19. ↑ "Standout voices in African public health". harvardpublichealth.org. 13 September 2023. Retrieved 13 September 2023.
  20. ↑ Blaine, Sue (13 September 2023). "Helen Rees awarded R1.5m Oppenheimer fellowship". Business Live. Retrieved 13 September 2023.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.